{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:06:16Z","timestamp":1789571176562,"version":"build-2803163510"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Introduction<\/jats:title><jats:p>Patients with minor ischemic stroke or transient ischemic attack represent a high-risk population for recurrent stroke. No direct comparison exists comparing dual antiplatelet therapy regimens\u2014namely, Ticagrelor and Aspirin versus Clopidogrel and Aspirin. This systematic review and network meta-analysis (NMA) will examine the efficacy of these two different antiplatelet regimens in preventing recurrent stroke and mortality up to 30 days.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods and analysis<\/jats:title><jats:p>MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials (CENTRAL) will be searched with the assistance of a medical information specialist. Two independent reviewers will screen studies for inclusion; eligible studies will include randomized controlled trials that enrolled adults presenting with acute minor ischemic stroke or transient ischemic attack and compared one or more of the interventions against each other and\/or a control. The primary outcomes will be recurrent ischemic stroke up to 30 days from symptom onset. Secondary outcomes will include safety outcomes (I.e. major bleeding and mortality), functional disability, and outcomes up to 90 days from symptom onset. A Bayesian approach to NMA will be implemented using the BUGSnet function in R Software. Between group comparisons for time-to-event (TTE) and dichotomous outcomes will be presented in terms of hazard ratios and odds ratios with 95% credible intervals, respectively. Secondary effect measures of treatment ranking will also be estimated.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Ethics and dissemination<\/jats:title><jats:p>No formal research ethics approval are necessary. We will disseminate our findings through scientific conference presentations, peer-reviewed publications, and social media\/the press. The findings from this review will aid clinicians in decision-making on the choice of antithrombotic therapy in a high-risk stroke population and could be important in the development of future treatment trials and guidelines.<\/jats:p><jats:p>Registration ID with Open Science Framework:<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/doi.org\/10.17605\/OSF.IO\/XDJYZ\" xlink:type=\"simple\">10.17605\/OSF.IO\/XDJYZ<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0250553","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T18:35:15Z","timestamp":1619634915000},"page":"e0250553","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ticagrelor vs Clopidogrel in addition to Aspirin in minor ischemic stroke\/ transient ischemic attack\u2014Protocol for a systematic review and network meta-analysis"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4409-8893","authenticated-orcid":true,"given":"Gabriele","family":"Zitikyte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle Carole","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Dhaliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8455-8201","authenticated-orcid":true,"given":"Ronda","family":"Lun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Shorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dar","family":"Dowlatshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"key":"pone.0250553.ref001","doi-asserted-by":"crossref","first-page":"k5108","DOI":"10.1136\/bmj.k5108","article-title":"Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis","volume":"363","author":"Q Hao","year":"2018","journal-title":"BMJ"},{"key":"pone.0250553.ref002","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/0976-7800.179166","article-title":"Risk factors of transient ischemic attack: An overview","volume":"7","author":"S Khare","year":"2016","journal-title":"J -Life Health"},{"key":"pone.0250553.ref003","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1056\/NEJMoa1802712","article-title":"Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke","volume":"378","author":"P Amarenco","year":"2018","journal-title":"N Engl J Med"},{"key":"pone.0250553.ref004","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1161\/STROKEAHA.107.513234","article-title":"Recurrent Events in Transient Ischemic Attack and Minor Stroke","volume":"39","author":"B Coutts Shelagh","year":"2008","journal-title":"Stroke"},{"key":"pone.0250553.ref005","doi-asserted-by":"crossref","first-page":"l895","DOI":"10.1136\/bmj.l895","article-title":"Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack","volume":"364","author":"Y Wang","year":"2019","journal-title":"BMJ"},{"key":"pone.0250553.ref006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1215340","article-title":"Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack","volume":"369","author":"Y Wang","year":"2013","journal-title":"N Engl J Med"},{"key":"pone.0250553.ref007","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa1800410","article-title":"Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA","volume":"379","author":"SC Johnston","year":"2018","journal-title":"N Engl J Med"},{"key":"pone.0250553.ref008","first-page":"e344","article-title":"Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association","volume":"50","author":"J Powers William","year":"2019","journal-title":"Stroke"},{"key":"pone.0250553.ref009","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1177\/1747493018786616","article-title":"Canadian Stroke Best Practice Recommendations for Acute Stroke Management: Prehospital, Emergency Department, and Acute Inpatient Stroke Care, 6th Edition, Update 2018","volume":"13","author":"J Boulanger","year":"2018","journal-title":"Int J Stroke"},{"key":"pone.0250553.ref010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/00207454.2012.744308","article-title":"Genetic Polymorphisms and Drug Interactions Leading to Clopidogrel Resistance: Why the Asian Population Requires Special Attention","volume":"123","author":"MS Hasan","year":"2013","journal-title":"Int J Neurosci"},{"key":"pone.0250553.ref011","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2010.04.047","article-title":"Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate","volume":"56","author":"Bonello Laurent","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"pone.0250553.ref012","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.116.024913","article-title":"Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis","volume":"135","author":"Y Pan","year":"2017","journal-title":"Circulation"},{"key":"pone.0250553.ref013","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/phar.1477","article-title":"Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety","volume":"34","author":"PP Dobesh","year":"2014","journal-title":"Pharmacotherapy"},{"key":"pone.0250553.ref014","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJMoa1916870","article-title":"Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA","volume":"383","author":"SC Johnston","year":"2020","journal-title":"N Engl J Med"},{"key":"pone.0250553.ref015","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"S Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"pone.0250553.ref016","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","article-title":"An Updated Definition of Stroke for the 21st Century","volume":"44","author":"L Sacco Ralph","year":"2013","journal-title":"Stroke"},{"key":"pone.0250553.ref017","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"JAC Sterne","year":"2019","journal-title":"BMJ"},{"key":"pone.0250553.ref018","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/jamaneurol.2019.2531","article-title":"Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials","volume":"76","author":"Y Pan","year":"2019","journal-title":"JAMA Neurol"},{"key":"pone.0250553.ref019","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-12-9","article-title":"Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves","volume":"12","author":"P Guyot","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"pone.0250553.ref020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jid.2018.10.028","article-title":"Research Techniques Made Simple: Network Meta-Analysis","volume":"139","author":"J Watt","year":"2019","journal-title":"J Invest Dermatol"},{"key":"pone.0250553.ref021","doi-asserted-by":"crossref","unstructured":"Chaimani A, Caldwell DM, Li T, Higgins JPT, Salanti G. Chapter 11: Undertaking network meta-analyses. Cochrane Handbook for Systematic Reviews of Interventions version 61 (updated September 2020). Cochrane; 2020. www.training.cochrane.org\/handbook.","DOI":"10.1002\/9781119536604.ch11"},{"key":"pone.0250553.ref022","doi-asserted-by":"crossref","first-page":"e99682","DOI":"10.1371\/journal.pone.0099682","article-title":"Evaluating the Quality of Evidence from a Network Meta-Analysis","volume":"9","author":"G Salanti","year":"2014","journal-title":"PLOS ONE"},{"key":"pone.0250553.ref023","unstructured":"Harrer M, Cuijpers P, Furukawa TA, Ebert DD. Doing Meta-Analysis in R. https:\/\/bookdown.org\/MathiasHarrer\/Doing_Meta_Analysis_in_R\/."},{"key":"pone.0250553.ref024","first-page":"943","article-title":"Network meta-analysis: a technique to gather evidence from direct and indirect comparisons","volume":"15","author":"FS Tonin","year":"2017","journal-title":"Pharm Pract"},{"key":"pone.0250553.ref025","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/jrsm.1195","article-title":"GetReal in network meta-analysis: a review of the methodology","volume":"7","author":"O Efthimiou","year":"2016","journal-title":"Res Synth Methods"},{"key":"pone.0250553.ref026","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12874-019-0829-2","article-title":"BUGSnet: an R package to facilitate the conduct and reporting of Bayesian network Meta-analyses","volume":"19","author":"A B\u00e9liveau","year":"2019","journal-title":"BMC Med Res Methodol"},{"key":"pone.0250553.ref027","unstructured":"Dias S, Welton NJ, Sutton AJ, Caldwell DM, Lu G, Ades AE. NICE DSU Technical Support Document 4: Inconsistency in Networks of Evidence Based on Randomised Controlled Trials. 2011 [cited 10 Mar 2021]. https:\/\/research-information.bris.ac.uk\/en\/publications\/nice-dsu-technical-support-document-4-inconsistency-in-networks-o."},{"key":"pone.0250553.ref028","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.prevetmed.2007.01.003","article-title":"Assessing the convergence of Markov Chain Monte Carlo methods: An example from evaluation of diagnostic tests in absence of a gold standard","volume":"79","author":"N Toft","year":"2007","journal-title":"Prev Vet Med"},{"key":"pone.0250553.ref029","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"G Salanti","year":"2011","journal-title":"J Clin Epidemiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0250553","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,25]],"date-time":"2022-12-25T19:05:20Z","timestamp":1671995120000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0250553"}},"subtitle":[],"editor":[{"given":"Aristeidis H.","family":"Katsanos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0250553","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,28]]}}}